Adenosine A2A receptor, a potential valuable target for controlling reoxygenated DCs-triggered inflammation

Molecular Immunology

Volumn 63, Issue 2, 2015, Pages 559-565

  Liu, Chunmei ^a,b   Shang, Qianwen ^a   Bai, Yang ^a   Guo, Chun ^a   Zhu, Faliang ^a   Zhang, Lining ^a   Wang, Qun ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Adenosine receptor; Dendritic cells; Hypoxia; Inflammation; Reoxygenation

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; B7 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; 2-(4-(2-CARBOXYETHYL)PHENETHYLAMINO)-5'-N-ETHYLCARBOXAMIDOADENOSINE; ADENOSINE; AUTACOID; CYTOKINE; MESSENGER RNA; OXYGEN; PHENETHYLAMINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL HYPOXIA; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; IMMUNOREGULATION; INFLAMMATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; REOXYGENATION; SIGNAL TRANSDUCTION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; DRUG EFFECTS; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PHENOTYPE; SECRETION (PROCESS);

ADENOSINE; ANIMALS; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; FEMALE; INFLAMMATION; INFLAMMATION MEDIATORS; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; OXYGEN; PHENETHYLAMINES; PHENOTYPE; RECEPTOR, ADENOSINE A2A; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84912027504     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.10.012     Document Type: Article

References (28)

1. Ben Addi A., Lefort A., Hua X., Libert F., Communi D., Ledent C., Macours P., Tilley S.L., Boeynaems J.M., Robaye B. Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor. Eur. J. Immunol. 2008, 38:1610-1620.
2. Boros P., Bromberg J.S. New cellular and molecular immune pathways in ischemia/reperfusion injury. Am. J. Transplant. 2006, 6:652-658.
3. Castellaneta A., Yoshida O., Kimura S., Yokota S., Geller D.A., Murase N., Thomson A.W. Plasmacytoid dendritic cell-derived IFN-alpha promotes murine liver ischemia/reperfusion injury by induction of hepatocyte IRF-1. Hepatology 2014, 60:267-277.
4. Dong X., Swaminathan S., Bachman L.A., Croatt A.J., Nath K.A., Griffin M.D. Antigen presentation by dendritic cells in renal lymph nodes is linked to systemic and local injury to the kidney. Kidney Int. 2005, 68:1096-1108.
5. Dong X., Swaminathan S., Bachman L.A., Croatt A.J., Nath K.A., Griffin M.D. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 2007, 71:619-628.
6. Hasko G., Csoka B., Nemeth Z.H., Vizi E.S., Pacher P. A(2B) adenosine receptors in immunity and inflammation. Trends Immunol. 2009, 30:263-270.
7. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992, 176:1693-1702.
8. Jang H.R., Ko G.J., Wasowska B.A., Rabb H. The interaction between ischemia-reperfusion and immune responses in the kidney. J. Mol. Med. (Berl.) 2009, 87:859-864.
9. Kutala V.K., Khan M., Angelos M.G., Kuppusamy P. Role of oxygen in postischemic myocardial injury. Antioxid. Redox Signal. 2007, 9:1193-1206.
10. Li C., Jackson R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell Physiol. 2002, 282:C227-C241.
11. Li L., Huang L., Ye H., Song S.P., Bajwa A., Lee S.J., Moser E.K., Jaworska K., Kinsey G.R., Day Y.J., et al. Dendritic cells tolerized with adenosine A(2)AR agonist attenuate acute kidney injury. J. Clin. Invest. 2012, 122:3931-3942.
12. Loi P., Paulart F., Pajak B., Nagy N., Salmon I., Moser M., Goldman M., Flamand V. The fate of dendritic cells in a mouse model of liver ischemia/reperfusion injury. Transplant. Proc. 2004, 36:1275-1279.
13. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999, 223:77-92.
14. Novitskiy S.V., Ryzhov S., Zaynagetdinov R., Goldstein A.E., Huang Y., Tikhomirov O.Y., Blackburn M.R., Biaggioni I., Carbone D.P., Feoktistov I., et al. Adenosine receptors in regulation of dendritic cell differentiation and function. Blood 2008, 112:1822-1831.
15. Panther E., Corinti S., Idzko M., Herouy Y., Napp M., la Sala A., Girolomoni G., Norgauer J. Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 2003, 101:3985-3990.
16. Panther E., Idzko M., Herouy Y., Rheinen H., Gebicke-Haerter P.J., Mrowietz U., Dichmann S., Norgauer J. Expression and function of adenosine receptors in human dendritic cells. FASEB J. 2001, 15:1963-1970.
17. Sitkovsky M., Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat. Rev. Immunol. 2005, 5:712-721.
18. Sitkovsky M., Ohta A. Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer. J. Mol. Med. (Berl.) 2013, 91:147-155.
19. Sitkovsky M.V., Lukashev D., Apasov S., Kojima H., Koshiba M., Caldwell C., Ohta A., Thiel M. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 2004, 22:657-682.
20. Thiel M., Chouker A., Ohta A., Jackson E., Caldwell C., Smith P., Lukashev D., Bittmann I., Sitkovsky M.V. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 2005, 3:e174.
21. Wang J.Y., Shum A.Y., Wang J.Y. Hypoxia/reoxygenation induces cell injury via different mechanisms in cultured rat cortical neurons and glial cells. Neurosci. Lett. 2002, 322:187-191.
22. Wang Q., Liu C., Zhu F., Liu F., Zhang P., Guo C., Wang X., Li H., Ma C., Sun W., et al. Reoxygenation of hypoxia-differentiated dentritic cells induces Th1 and Th17 cell differentiation. Mol. Immunol. 2010, 47:922-931.
23. Wilson J.M., Ross W.G., Agbai O.N., Frazier R., Figler R.A., Rieger J., Linden J., Ernst P.B. The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells. J. Immunol. 2009, 182:4616-4623.
24. Yamauchi M., Kimura H. Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications. Antioxid. Redox Signal. 2008, 10:755-768.
25. Yang M., Ma C., Liu S., Shao Q., Gao W., Song B., Sun J., Xie Q., Zhang Y., Feng A., et al. HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia. Immunol. Cell Biol. 2010, 88:165-171.
26. Yang Z., Day Y.J., Toufektsian M.C., Ramos S.I., Marshall M., Wang X.Q., French B.A., Linden J. Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes. Circulation 2005, 111:2190-2197.
27. Zhai Y., Busuttil R.W., Kupiec-Weglinski J.W. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am. J. Transplant. 2011, 11:1563-1569.
28. Zhou T., Sun G.Z., Zhang M.J., Chen J.L., Zhang D.Q., Hu Q.S., Chen Y.Y., Chen N. Role of adhesion molecules and dendritic cells in rat hepatic/renal ischemia-reperfusion injury and anti-adhesive intervention with anti-P-selectin lectin-EGF domain monoclonal antibody. World J. Gastroenterol. 2005, 11:1005-1010.